The efficacy and adverse reactions of vaccination against measles

Vaccination against measles is carried out to those children at the age of 12 or 15 months who is not sick with measles, re the vaccine is children at the age of six years. It is necessary for the formation of collective immunity, as well as in the case of a weak immune system, formed after the first vaccination.

According to the immunization schedule, measles vaccine is placed simultaneously with the vaccine against mumps, rubella and hepatitis B.

The effectiveness of vaccination against measles

If all the rules of the vaccination immunity is developed almost in 100% of cases in children of the second year about a month after the injection. The immunity lasts 25 years, and only in a few cases, it may fade over time.

Complications of vaccination against measles

Measles vaccine causes side effects in rare cases. The majority of children vaccinated against measles does not cause any complications, and only about 10% of cases of vaccination accompanied by fever, catarrhal symptoms, small rash. When the tendency to allergic reactions the rash may appear in the first hours after vaccination. On the second or third day all the reactions to the drug are. In any case, the child is not a danger to others.

In children with higher allergic background may be rash, urticaria, angioedema, in rare case complications appear in the form of anaphylactic shock to egg white.

The fever in some children who are predisposed to such complications may provoke seizures. To prevent such consequences it is recommended to give the child on the fifth day after vaccination, paracetamol.

Met in pediatric cases of subacute sclerosing panencephalitis in children who had not previously suffered from measles and which was delivered to the measles vaccine. The likelihood of developing such complications – one in a million doses, substantially less than in pathology. When measles subacute sclerosing panencephalitis occurs in 6 to 22 cases per million cases. According to the results of a retrospective study, which was conducted by the center for disease control, the vaccine helps prevent subacute sclerosing panencephalitis, reducing the number of cases of measles.

Extremely rare after the introduction oftriactive found thrombocytopenia, even more rare cases, after setting single or.

In medicine also described a case of toxic shock due to Staphylococcus aureus infection after contamination of opened vials of the drug.